产品名称
环戊基苯乙酸, 97%
InChI key
BCJIDGDYYYBNNB-UHFFFAOYSA-N
InChI
1S/C13H16O2/c14-13(15)12(11-8-4-5-9-11)10-6-2-1-3-7-10/h1-3,6-7,11-12H,4-5,8-9H2,(H,14,15)
SMILES string
OC(=O)C(C1CCCC1)c2ccccc2
assay
97%
form
solid
mp
98-100 °C (lit.)
solubility
methanol: soluble 50 mg/mL, clear, colorless
functional group
carboxylic acid
phenyl
Quality Level
正在寻找类似产品? 访问 产品对比指南
Application
Cyclopentylphenylacetic acid was used in the synthesis of:
- 1-cyclopentyl-l-phenyl-2-(p-alkoxyphenyl)ethylenes
- soft ester analogs of anticholinergics
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
法规信息
新产品
此项目有
664. Chemical constitution and sex-hormonal activity: the synthesis of of some 1-cyclopentyl-and 1-cyclohexyl-1: 2-diarylethylenes.
Hey DH and Musgrave OC.
Journal of the Chemical Society, 3156-3164 (1949)
N Bodor et al.
Journal of medicinal chemistry, 23(5), 474-480 (1980-05-01)
A new class of antimuscarinic drugs was designed and synthesized. The compounds are "soft" quaternary ammonium esters in which there is only one carbon atom separating the ester oxygen and the quaternary head. The compounds are potent anticholinergics when derived
B Liebmann et al.
Arzneimittel-Forschung, 42(11), 1354-1358 (1992-11-01)
Ester hydrolysis represents an important biotransformation pathway for various parasympatholytic agents. Cleavage of the ciclotropium ester bond results in the formation of alpha-phenylciclopentylacetic acid (PCA). The relevance of this metabolic route for ciclotropium bromide (HIT-PCE, CAS 85166-20-7) including its stereochemical
F Huang et al.
Die Pharmazie, 57(2), 115-121 (2002-03-07)
Four new soft anticholinergic agents based on tropyl alpha-phenylcyclopentylacetate, 15a, 15b, 18a, and 18b, were designed and synthesized. Receptor binding studies on the cloned human muscarinic receptors indicated that the new soft anticholinergic agents possessed moderate potency as pKi ranged
Radoslaw Laufer et al.
Bioorganic & medicinal chemistry, 22(17), 4968-4997 (2014-07-22)
TTK kinase was identified by in-house siRNA screen and pursued as a tractable, novel target for cancer treatment. A screening campaign and systematic optimization, supported by computer modeling led to an indazole core with key sulfamoylphenyl and acetamido moieties at
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持